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Objective: HLA-C*16:04:01 and HLA-B*15:109 are two uncommon alleles at the HLA-C locus and HLA-B
locus, respectively. The objective of this study is to report the deduced probable human leukocyte
antigen (HLA) haplotypes associated with HLA-C*16:04:01 and HLA-B*15:109 among Taiwanese unre-
lated bone marrow hematopoietic stem cell donors.
Materials and methods: A sequence-based typing method was employed to conﬁrm the two low inci-
dence alleles observed. Polymerase chain reaction was performed to amplify exons 2 and 3 of the HLA-A,
and HLA-B loci with group-speciﬁc primer sets. Amplicons were sequenced using a BigDye Terminator
Cycle Sequencing Ready Reaction Kit in both directions according to the manufacturer's protocols.
Results: The DNA sequence of C*16:04:01 is identical to that of C*16:01:01 in exons 2 and 3, except for
two nucleotide substitutions at residues 538 (C->T) and 539 (A->G), which results in a single amino acid
replacement at position 156 (glutamine->tryptophan). We deduced two probable HLA haplotypes that
are found in association with C*16:04:01 as A*33:03-B*44:02-C*16:04:01-DRB1*11:04 and A*24-
B*44:02-C*16:04:01-DRB1*11:04. The DNA sequence of B*15:109 is identical to B*15:27:01 in exons 2
and 3 except for one nucleotide substitution at residue 200 (C->T), which results in a single amino acid
replacement at position 43 (proline->leucine). A probable HLA haplotype associated with B*15:109 was
deduced to be A*11-B*15:109-DRB1*04.
Conclusion: Information on the deduced HLA haplotypes that are found in association with the rare
C*16:04:01 and B*15:109 alleles that we report here is useful for reference purposes at HLA testing
laboratories and will help stem cell transplantation donor search coordinators when they are deter-
mining the likelihood of ﬁnding a compatible donor for patients bearing these two uncommon HLA
alleles from unrelated bone marrow donor registries.
Copyright © 2014, Buddhist Compassion Relief Tzu Chi Foundation. Published by Elsevier Taiwan LLC. All
rights reserved.lls Centre, Buddhist Tzu Chi
Hualien, Taiwan. Tel.: þ886
).
elief Tzu Chi Foundation. Publishe1. Introduction
Themajor histocompatibility complex (MHC) in humans consists
of several gene loci situated on the short arm of chromosome 6 at
6p21.3. These loci are classiﬁed into three MHC classes; I, II, and III.
The genes encoding the human leukocyte antigen (HLA) alleles are
located in the MHC class I and II regions. The HLA genes are char-
acterized by their extreme allelic polymorphism as well as their
high variation and diversity among different ethnic groups andd by Elsevier Taiwan LLC. All rights reserved.
Fig. 1. The DNA sequence of C*16:04:01 is identical to C*16:01:01 in exons 2 and 3, except for two nucleotide substitutions at residues 538 (C->T) and 539 (A->G) (shaded).
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deﬁned to be transplant antigens and have strong relevance when
tissue transplantation is carried out. The similarity of these protein
molecules between donors and recipients is being considered to be
an important factor when predicting graft survival and graft versus
host disease (GVHD). It is very important to precisely characterize
any new allele encountered during routine HLA typing procedures.
To facilitate successful and comprehensive unrelated bone marrow
donor searches for patients in need of hematopoietic stem cell
transplantation, we are persistently working on resolving uniden-
tiﬁed or ambiguous alleles that pass through our hands in order to
offer better HLAmatching and donor selection as part of our service.
HLA-C*16:04:01 and HLA-1*15:109 were ﬁrst reported to the
IMGT/HLA database in 1997 (HC 11164; HC 11181) and 2006
(HC14070), respectively [1]. Here, we report the deduced probable
HLA haplotypes that are found in association with C*16:04:01 and
B*15:109. We further postulate that there are two plausible HLA
haplotypes found in association with C*16:04:01 in Taiwanese and
that the haplotype in association with B*15:109 is likely to beFig. 2. The nucleotide substitutions of C*16:04:01 cause an amino acirestricted to Oriental populations, due to the fact that it has so far
been reported only in Singapore [1] and in Taiwan.
2. Materials and methods
Peripheral whole blood samples from the unrelated bone
marrow stem cell donors with Taiwanese ethnicity were collected
in acid citrate dextrose (ACD) anticoagulant. Formal written con-
sent was signed by the donors prior to blood collection. The ACD
whole blood was stored at 80C until use. Genomic DNA was
extracted using a QIAamp DNA Blood Mini Kit (Qiagen, Hilden,
Germany) according to the manufacturer's instructions. The DNA
was then subjected to HLA genotyping for HLA-A, HLA-B, and HLA-
DRB1 loci using a commercial PCR-SBT kit and a SeCore A/B/DRB1
Locus Sequencing kit (Life Technologies, Brown Deer, WI, USA).
High resolution allelic sequencing was performed as previously
described [2e6]. Amplicons were sequenced using a BigDye
Terminator Cycle Sequencing Ready Reaction Kit (Applied Bio-
systems, Foster City, CA, USA) in both directions.d replacement at residue 156 (glutamine->tryptophan) (shaded).
Table 1
The HLA-A, HLA-B, HLA-C, and HLA-DRB1* alleles of bone marrow donors with
C*16:04:01.
HLA- HLA-A* HLA-B* HLA-C* HLA-DRB1*
Donor 1 33:03 11:01 44:02 15:02 16:04:01 08:01 11:04 12:02
Donor 2 33:03 11:02 44:02 40:01 16:04:01 04:01 11:04 04:04
Donor 3 33:03 11:01 44:02 15:02 16:04:01 08:01 11:04 12:02
Donor 4 33:03 11:01 44:02 40:01 16:04:01 03:04 11:04 04:03
Donor 5 24:02 02:01 44:02 40:02 16:04:01 07:02 11:04 09:01
Donor 6 24 02 44:02 40:02 16:04:01 03:03 11:04 14:54
K.-L. Yang et al. / Tzu Chi Medical Journal 26 (2014) 123e126 1253. Results
We conﬁrmed the DNA sequence of C*16:04:01 to be identical to
C*16:01:01 in exons 2 and 3, except for the presence of two
nucleotide substitutions at residues 538 (C->T) and 539 (A->G)
(Fig. 1). The nucleotide substitutions result in an amino acid
replacement at residue 156 (glutamine>tryptophan) (Fig. 2). The
extended HLA typings of our donors who are carrying C*16:04:01
are shown in Table 1. Taken all together, two HLA-A, HLA-B, HLA-C,
and HLA-DRB1 haplotypes may be deduced and these are A*33:03-
B*44:02-C*16:04:01-DRB1*11:04 and A*24-B*44:02-C*16:04:01-
DRB1*11:04. Because the haplotype A*24-B*44:02-C*16:04:01-
DRB1*11:04 was initially found in an Italian individual [7], we as-
sume this C*16:04:01 associated HLA haplotype is a European and
Oriental haplotype, whereas the haplotype A*33:03-B*44:02-
C*16:04:01-DRB1*11:04 is an Asian haplotype. In addition, it is
apparent that C*16:04:01 is in linkage with B*44:02 and
DRB1*11:04, because all donors bearing C*16:04:01 also carry
B*44:02 and DRB1*11:04 (Table 1).
We conﬁrmed the DNA sequence of B*15:109 to be identical to
B*15:27:01 in exons 2 and 3 except for a single nucleotide substi-
tution at residue 200 (C->T) (Fig. 3). The nucleotide substitution
results in one amino acid replacement at position 43 (proline>-
leucine) (Fig. 4). Extended HLA typing of our donor who carried
B*15:109 is: A*11:XEWG, A*11:PDVH, B*15:109, B*40:NPHZ,
DRB1*04:HAJB, and DRB1*08:ANM. When this is taken together
with the extended HLA typing of the Singapore donor with
B*15:109 that has been reported to the IMGT/HLA database (HC
14070) (A*02ANDC, A*11:XSH, B*15:109, B*54:01, DRB1*04:ASEJ
and DRB1*15:GEP), the probable HLA haplotype found in associa-
tion with B*15:109 may be postulated to be A*11-B*15:109-
DRB1*04. We speculate that the haplotype A*11-B*15:109-
DRB1*04 is most probably limited to Asian populations, because
B*15:109 has been only found in Asian individuals. Our speculation
remains to be veriﬁed in the future.Fig. 3. The DNA sequence of B*15:109 is identical to B*15:27:01 in exons 2 an4. Discussion
We have conﬁrmed in this study the DNA sequences and amino
acid sequences of the two low frequency HLA alleles, C*16:04:01
and B*15:109. C*16:04:01 was initially detected in a family from
south Italy and subsequently found in three unrelated Mediterra-
nean Caucasoid donors [7]. C*16:04: 01 could possibly result from a
gene conversion-like recombination event involving C*16:01 as
recipient and any one of the Trp 156-positive alleles (C*02, C*06
and C*12) as donor [7]. We deduced twomost probable C*16:04:01
associated HLA haplotypes from our unrelated bone marrow do-
nors, one of which, (A*24-B*44:02-C*16:04:01-DRB1*11:04), is a
European and Asian haplotype, and was also identiﬁed in an Italian
individual as reported by Grundschober et al [7]. We further
deduced another C*16:04:01 associated HLA haplotype (A*33:03-
B*44:02-C*16:04:01-DRB1*11:04) based on our Taiwanese popu-
lation. We presume the second C*16:04:01 associated HLA haplo-
type is most likely restricted to the Taiwanese population.
Furthermore, we veriﬁed a probable HLA haplotype that is found in
association with B*15:109. We think B*15:109, like its associated
probable HLA haplotype, is likely to be restricted to Oriental
populations.
The signiﬁcance of determining the ethnicity of C*16:04:01 and
B*15:109 and their linked HLA haplotypes is that such information
may be applied in anthropological investigations of races; in addi-
tion, it also allows search coordinators fromunrelated bonemarrow
donor registries to allocate appropriate unrelated bone marrow
hematopoietic stem cell donors to the appropriate patients.
It is worth mentioning that the most direct and classical method
of determining a HLA haplotype is through family studies if the test
materials from a number of key family members are available.
Alternatively, population study may be employed if a signiﬁcant
and sufﬁcient number of unrelated donors are available [8]. How-
ever, the haplotypes deduced via population investigations are
generally considered to be likely or most probable haplotypes
rather than conﬁrmed haplotypes. In this study, due to the type and
availability of the necessary test material, we were unable to
perform family studies on the donors with C*16:04:01 and
B*15:109. Therefore, we have opted to determine the haplotypes by
examining the HLA alleles carried in common by the unrelated
donors bearing the same alleles of interest. By the same token, if
determination of plausible HLA haplotypes is carried out for rare
frequency HLA alleles, the alleles shared in common by unrelated
individuals may be also employed to deduce the associated prob-
able haplotypes [9e16]. Thus, we took the opportunity to employ
six unrelated bone marrow stem cell donors with C*16:04:01 and
the one donor with B*15:109 in our Registry's database togetherd 3 except for one nucleotide exchange at residue 200 (C->T) (shaded).
Fig. 4. The nucleotide substitution of B*15:27:01 causes an amino acid replacement at residue 43 (proline->leucine) (shaded).
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HLA database (HC 14070) in order to determine the most probable
HLA haplotypes that are found in association with C*16:04:01 and
B*15:109 alleles, respectively. The frequencies of C*16:04:01 and
B*15:109 in Taiwanese are extremely rare and occur at about 1 in
20,000 according to our HLA typing dataset. Therefore, we think the
probable HLA-C*16:04:01 and HLA-B*15:109 associated haplotypes
that we have deduced in this study are highly likely to be correct.
The HLA alleles are exponentially increasing in number because
of recent improvements anddevelopments inDNA-basedmolecular
typing technology. By contrast, one important and outstanding fact
is that the HLA diversity of every ethnic group is unique and
important. Such information is important to securing safe outcomes
for stem cell transplantation by avoiding graft rejection; further-
more, it also helps us understand graft-versus-host disease. There-
fore, in addition to accurate determination of HLA rare alleles,
haplotype matching between donors and recipients is of signiﬁcant
beneﬁt topatients. Basedon the above, our endeavor,which is aimed
at resolving rare HLA alleles and determining their associated HLA
haplotypes, will be persisted with and continued into the future.
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